- Search BSI
- Verify a Certificate
Suggested region and language based on your location
Your current region and language
The EU-MDR Rule 21 applies to all substance-based medical devices and is a new rule for medical devices.
Gain an appreciation of the background to the inclusion of this new rule in the MDR and of expectations for the Conformity Assessment process.
Explore in-depth on Rule 21, its intent and focus on the borderline nature with medicinal products.
Explore the key aspects that manufacturers need to consider when developing a regulatory strategy.
Conformity Assessment process.
Common Issues and misinterpretation of the Rule 21 Devices.
Watch the webinar for an in-depth explore on Rule 21 and its intent and focus on the borderline nature with medicinal products.
Reach out and see how we can help guide you on your path to sustainable operational success.